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MEASUREMENT OF BONE FORMATION IN A 57 YEAR
OLD MAN BY MEANS OF TETRACYCLINES*
H . M . FROST, A. R. VILLANUEVA AND H . ROTH

Untfl Hiroshima and Nagasaki assumed international importance, the rates and
modes of bone turnover in man were primarily academic matters. The advent of atomic
weapons, weapons testing, the risks attendant to their manufacture and increasing
clinical use of radioisotopes made the physiology of bone turnover in man a practical
problem. Research intended to illuminate mechanisms, rates and quantities associated
with turnover of bone and bone-seeking substances has been hampered by limitations
imposed in using man as a laboratory animal. The immediate and latent risks attending administration of radioisotopes limit the applicability of existing radioanalytical
techniques to bone at the light microscopic level. The large and detafled body of
knowledge gained from animal work needs qualitative and quantitative corroboration
in man before it can be applied to him. As a result of this state of affairs and others
undiscussed, we do not have actual measurements of bone-forming activity in man
at present. Such measurements are increasingly necessary for work in the fields of
radiobiology, osteoporosis of afl types, osteomalacia, growth and fracture healing.
This paper ampflfles basic work of Mflch, Rail and Tobie."." They noted the
fixation of tetracycline antibiotics in mineralizing parts of the skeleton (tetracycline bone
labelling) and subsequently detected the drugs by fluorescence in undecalcified bone
sections. Our contributions to their work include amplification of the optical behavior
of achromycin," an economical method of observing tetracycline fluorescence in bone"
and iflustration with a single human case of the kind of information which tetracycline
labelling may yield.
We feel the chief value of this paper is that it presents simple, reliable, effective
and precise techniques for measuring bone formation in man in vivo. With these
techniques, it should be possible to determine with considerable precision the factors
affecting human osteoblastic activity.
Tetracycline bone labelling has the advantages of little immediate and no known
latent risk. Numerous opportunities in large medical centers occur to obtain human
tetracycline labelled bone from both sexes, all ages and diverse disease states. Use
of tetracyclines in human experimentation should be safe.
By virtue of their permanent fixation in mineralizing, new skeletal tissue the
tetracyclines label bone forming activity current during the period of drug dosage.'^'"'"."
Suitable preparation and examination of bones from patients who received tetracyclines
at known times and for known duration permits us to measure their bone turnover
more than 6 years after tetracycline administration. It is an eerie feeling to realize
that one can measure precisely the osteoblastic activity going on in a bone 6 or more
years before the patient died!"
Using tetracycline labelled bone from 43 patients, and with the aid of methods
largely developed in the Henry Ford Hospital Orthopaedic Research Laboratory, we
*Supported by Grant No. 293, Henry Ford Hospital.
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have been able to measure in man, in vivo: the biological half life of Haversian bone;
the biological half life of entire bones; rates, quantities and variations in remodelling
activity in different bones; osteoblastic activity; and the time required to form
Haversian systems.
In this paper the methods used for such measurements are outlined through
the device of analyzing one human case. Some of the kinds of information that can
be wrung from tetracycline labelling are presented for this case. Presentation of detailed measurements of large numbers of human cases, and the effects of disease on
bone turnover, will be presented in separate publications.
MATERIALS
The materials studied herein are the middle thirds of the femur, tibia, fibula and
entire second metatarsal of the amputated left lower extremity. Corroboratory material
for some of the minor points presented in the following paragraphs are sections made
as recommended from more than 40 other patients who received tetracyclines before
death or surgery." Clinical details of the case are presented in Appendix ( A ) .
METHODS
Four or more complete cross sections of the listed bones were made, stained
and mounted by Frost's techniques.'.'
Fluorescence: As noted by Mflch and coworkers"." refrigeration does not affect
tetracycline fluorescence in bone. Material stored in bulk 8 months is unaffected.
Thin sections kept in ethanol, however, gradually lose their fluorescence over many
weeks. Permanent mounts made as recommended have not faded perceptibly in 3 years.
Tetracycline fixed in bone in vivo does fade perceptibly after 6 years of life."
The microfluorescence equipment used by Milch and coworkers is excellent.
Fluorescence can also be energized by a 430 mu band in the visual spectrum. A set-up
for this method is Wratten 47 and 47B filters in series in the light source and Wratten
8 and 9 filters in series over the eyepiece. The light source should be a high intensity
tungsten source such as a 300 watt 35 mm slide projector. Kohler illumination is
superior to others with this arrangement.' Tetracyclines fixed in tissue fluoresce strongly
with this arrangement. Their color is white to gold depending on drug concentration
and section thickness. Background is a faint green or magenta. Fluorescence may be
proved by passing the Wratten 8 filter under the condenser, whereupon fluorescence
abruptly ceases. The condenser should be racked close to the slide and the aperture
stop be wide open. For further details consult reference (13). See Figure 2.
Yellow color in bright field Microscopy: Achromycin" in achromycin-Iabelled
sections prepared as recommended'.' develops a lemon yellow color within one to 14
days of mounting (in Harleco synthetic resin-xylene)." Failure to stain and mount
as recommended usually prevents this color from appearing. The color does not
develop in bulk material. Once developed it appears to be permanent as long as
(a) All of the currently available tetracycline antibiotics, singly or in combination, are nearly equally
suitable for work of the type described in this paper.
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the mount is preserved. The visible yellow areas correspond precisely to the fluorescent
areas. Very thin planes of achromycin labelling, or zones labefled during time of low
dosage, may not develop detectable yellow in bright field but will fluoresce.
Appearance of tetracycline labelled bone: Labelled bone appears as yellow-stained
bands, the bands being paraflel to and in the substance of lameflae. Bands do not
cross lamellae or cement lines. The drug deposits in mineralizing bone and cartilage
and appears fixed there by subsequent mineralization. No diffusion out of labelled
volumes of bone has been seen in mounts 3 years old or in bulk material 8 months
old. The labelled band-width is a direct function of duration of dosage and rate
of mineralization of osteoid while intensity of fluorescence and visual yellow is a
function of dosage per day. When life continues after cessation of dosage the labelled
bone and calcified cartilage become buried by unlabefled bone and calcified cartilage
unless appositional growth ceased during drug administration. During the period of
tetracycline administration most tissues are stained by the drug. Within 48 hours of
drug cessation "adventitious" tetracycline has disappeared from bone, leaving only
the labelled bone and calcified cartilage behind as a tell-tale. This and other observations suggest to us that tetracycline staining of bone is ordinarily a readily reversible
phenomenon due at least in part to the ability of tetracycline antibiotics to complex
with calcium ions. For further details consult references (12, 26, 27).
Permanent staining of Haversian canals, osteocyte lacunae in Haversian systems
and calcified cartilage (which were mature during the period of drug administration)
has not been seen."."."
Observation of the visual yellow in tetracycline labelled undecalcified sections
is aided by use of light corrected to 5000°K, apochromats and fully illuminated objectives.'."
Photomicrography: The visual yeflow in brightfield is due
tetracycline energized by the blue end of the visible spectrum
photographed on ordinary black and white emulsions; excellent
graphs with Ektachrome, and black and white with fluorescence,
(See Figs. 1 and 2).

to fluorescence of
and so cannot be
color photomicrocan be obtained.''.'

MEASUREMENT METHODOLOGY
In order to measure bone turnover in man, we must be able to measure the amount
of new bone formed in a unit volume of bone in a unit of time. Tetracyclines administered in vivo conveniently label bone actively forming, and conveniently they do not
label unmineralized osteoid or already mineralized bone. The tetracycline labelling
process supplies the same type of information one would obtain by feeding large
amounts of alizarin to man, but without the toxicity associated with alizarin.
In the following material in the Methodology section, the actual measurements
required are outlined. In the Data Section, the manner in which the measurements
are manipulated to provide useful information is outlined. We make extensive reference
to other publications to shorten an already lengthy paper.
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'ieure I
Photomicrograph, Cross Section, femur, basic fuchsin, undecalcified, of the case presented in the
text. Brightfield, 200X. The black dots are vascular channels. The dark zone connecting the Haversian
channel at left midcenter to the Haversian channel at 2:00 o'clock is a Volkmann's canal which is
out of focus. The two Haversian channels are lying in newly formed Haversian systems and are still
fuchsin permeable in some areas, causing them to appear darker than the remainder of the bone
visible in this illustration. Parts of 3 Haversian systems banded by achromycin and pronouncedly
yellow on the original section are in this field but are not demonstrable on the photograph for
reasons referred to in the text.

Because of known distributional differences in various parts of single bones,
complete cross sections were necessary for the following measurements.".".''."." The
longitudinal grain of bone is associated with much less distributional variation along
the long axis than is found along the radial and tangential axes. Longitudinal sections
also provide too limited a sample. We emphasize here, ;ind will reemphasize later,
that the present measurements are done on the diaphyses of 4 bones of one patient
and must not be considered representative of norms for the sex and age of all similar
people.
The means of measurement used for the data in Charts I and I I are now presented.
1. Channels/mm'^: The slide was marked with a grid of lines which are scanned
in increments of one field diameter, using an objective-eyepiece combination of
known field diameter. The total numbers of longitudinally coursing vascular
channels and of fields are recorded and reduced to channels/mm^ by calculation. Relative variation in the present case was small, about 4%. Sampling
242
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Figure 2
Same field and magnification but with Frost's fluorescence set-up. The bright bands are achromycin
labelled parts of the Haversian systems. The left hand system is doubly banded, the outer band
being formed during the first, and the inner band during the second achromycin epoch of the case
discussed in the text. The right hand Haversian system is singly banded and it is not apparent
from the original material whether the band formed during the first or second epoch.

technique must be properly designed or systematic distributional effects inherent in bone and the observer will introduce error. For example there are
2 to 3 times as many channels near periosteal surfaces as near endosteal, while
osteon density and incidence of banded osteons is greater near bone angles
than in broad bone surfaces. For full details consult references (18, 19).
2. Percent osteons'^ labelled; labelled osteons per section; percent c^teoid seams;
percent seams in labelled osteons: Counts are done as in (1) using a fully
illuminated low power apochromat and color corrected light, tabulating
counts during the process with the aid of a hand counter. The complete sections,
rather than a sample, were scanned for labefled osteons per section, using the
mechanical stage to avoid under—or over lap. (Consult references 12, 18, 19,
for details of the measurement and for explanation of osteoid seams and
seam counts).
3. Osteons banded in outer, middle, inner thirds or doubly banded; banded
osteon lying in outer, middle or inner thirds of cortices: At any one time
(a) An osteon is an Haversian system.
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MEASURED

DATA

Chart I
Measured Characteristic
Longitudinal vascular channels/mm^
% Osteons Banded
(Number counted)

Femur

Tibia

Fibula

Metatarsal

13.2

14.1

12.2

16.2

2.1
5207

Number banded osteons per section,
average of 3 or more

149

0.65
2000
26

2.4
1448

1.06
662

24.5

9

24.5

11.1

21.7

35.1

28.6

25.8

30.4

25.6

28.6

Inner Third of Osteon Banded

47.0

47.8

38.4

43.3

Unclassifiable

11.0

11.7

20.6

22.2

% banded osteons with osteoid seam

4.7

3.8

Double banded osteons as %
all banded osteons

11.1

11.5

Outer Third of Osteon Banded

26.1

Middle Third of Osteon Banded

11.1

Banded Osteons Outer Third Cortex

56.3

95.7

84.3

100

Banded Osteons Middle Third Cortex

26.3

4.2

15.6

0

Banded Osteons Inner Third Cortex

17.3

0

MEASURED

0

DATA

Ch,'irt I i
Measured Characteristic

Femur

% Osteons Containing Osteoid Seam
at Amputation (2100 counted)

0.098

Average Osteon Width

80 u

Range

18.5 - 135 u

Average Width Labelled Bands,

19.9 u

Unselected Range

3.1 - 3 0 u

Average Width Outer and Middle
Third Bands

26.0 u

Average Width Inner Third Bands

6.0 u

% Section Surface Vascular Channel

10%

% Section Surface Banded

.58

% Empty Lacunae, Banded Osteons

2.1

% Empty Lacunae, Inner Third Band of
Doubly Banded Osteons

0.5%

% Empty Lacunae, Outer Third Band of
Doubly Banded Osteons

2.3%

% Empty Lacunae, Mature Haversian Systems

18.5

% Empty Lacunae, Extra-Haversian

55.7
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CALCULATED DATA: SEE TEXT

Chart I I I
DATA
Osteons/Banded Osteon
Bande<j Osteons/mm^
Mean Osteon Formation Time
Osteoid Seam Thickness Formed/Day
Instantaneous % Osteoid Seams
Instantaneous Quiescent
Osteons/Mineralizing Osteon
Biological Half Life, Entire Cortex
Years
Days
Biological Half Life, Osteons
Years
Days
% Osteons Remodelled per Year
% Mass (and os.seous volume less va.scular
and cell volume) Mineralizing/Day
% Mass i n Turnover/Day
Ratio of Remodelling Activity per Unit
Volume ( F e m u r = 1 0 0 )
Ratio of Remodelling Activity i n Term.s
Total Mass in Turnover ( F e m u r = 1 0 0 )
% Remodelling Activity in Outer Third Cortex

Femur

Tibia

Fibula

Metatarsal

45.4
0.290
5 wks.
2.4 u
0.75

154
0.091
5 wks.

41.4
0.294
5 wks.

94.3
0.176
5 wks.

—

—

—

0.23

0.86

0.38

125

430

115

262

7.6
2700

24.2
8600

7.6
2700

12.6
4500

2.7
960
18.7

8.6
3000
5.9

3,1
1100
21.4

5.6
2000
9.4

0.018
0.036

0.0058
0.012

0.018
0.036

100

31

101

61

100
56.3

19
95.7

15
84.3

7.5
100

0.011
0.022

in a given patient, some osteons will be in the initial stages of formation,
some in the final stages and some in between. Labelling with tetracycline
wifl accordingly appear, in the subsequently completed osten, as a band in
the outer, middle or inner third of the osteon. If two periods of drug dosage
were close enough together, then some osteons would exhibit double bands,
one within the other as in Figure 2. Banded osteons were tabulated separately
by completely scanning sections of femur, tibia, fibula and mentatarsal with
a low power apochromat.
344 banded osteons were counted for these
measurements.
Doubly banded osteons were counted twice. Of the total
banded osteons, 11 % could not be classitied as to the third of the osteon
banded JO these figures do not add up to 100%.
4. Average width" of osteon; average widths of labelled bands: Banded osteons
were selected at random and measured with a calibrated eye-piece micrometer.'." The totals were reduced to arithmetic means. 49 osteons were
measured for average osteon width; 29 unselected bands, 29 outer or middle
third bands and 29 inner third bands for average band widths. The average
osteon diameter is more than twice the listed value since the vascular canal
was ignored. The average would be about 240 u with a range of 40-300 u."
5. Percent empty lacunae: Reference" discusses the technique utilized in these
measurements. Briefly lacunae without stained contents are empty and dead.
More empty lacunae exist in extra-Haversian than in Haversian bone''. The
(a) Width here refers to the distance between cement line and Haversian canal along a radial axis.
See Figs. I and 2.
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inference is that increasing age of patient and bone moiety increases the
counts of empty lacunae. Lacunae opening into the section surfaces are
not counted. High numerical aperture is essential for the counts.
6. Percent section surface area: The theory of this technique is that in a well
mixed, multiphase solid, an infinitely thin plane cut through it will contain
proportionate surface areas of each phase in direct proportion to the volume
components of each phase in the solid, provided the area of the plane is
sufficientiy large to avoid random distributional effects. This ideal plane
may in turn be sampled by running the cross-hairs of a filar micrometer
across it, or by other means. Enough runs to reduce random distributional
effects below the desired level must be made. Consult references 15, 16, 19,
22, 23, for fuller detafls.
The Leitz integrating eyepiece micrometer was designed for the above
type of measurement. The microscope objective is used to provide the
measured plane, and means for mechanically adding the various phase
constituents measured are buflt into the instrumenL The femur was selected
for the measurements because of its greater homogeneity as compared to
the other bones. For example, the relative variation in counts of total
labelled osteons per section was only 0.6% in the femur, 4% in the tibia,
10% in the fibula and 20% in the metatarsal. This suggests that when
enough cross section area has been sampled the results are valid for adjacent
parts of a diaphysis, and that more sections of smafl bones must be measured
to achieve meaningful results."
In the present integrating eyepiece measurements, 12 fields were measured
at 150 X and 0.32 N.A. with full illumination of the objective. The estimated
probable error (a combination of instrument, resolving power, optical, section
thickness and operator effects)'."."."."." is plus or minus 10% for the vascular and 40% for the banded areas.
7. The volume of lacunae and canaliculae is 2.5% of the cortex exclusive of
vascular volume. This measurement is detailed in reference 16.
8. Charts I and I I list the values obtained for the measurements described above.
The data in Chart I I I are calculated from the data in Charts I and I I .
See foflowing text for the reasoning involved.
DATA ANALYSIS
1. Osteon turnover: Several informative calculations can be made from the
data in Charts I and I I . These calculations tefl us how many osteons are
being formed per unit time and per unit volume of diaphyseal bone. They
also tefl us the proportion of the total osteon population undergoing remodelling per unit time. From this the biological half-life of the osteon
population may be caculated for each diaphysis measured.
(b) Haversian bone as defined for the present purpose consists of intact osteons only. In double or
triple systems only the innermost one is considered Haversian. The remainder of the cortex is
designated extra-Haversian and includes circumferential lamellae and fragments of old osteons.

246

Measurement of Bone Formation
(A)

During the 40 days of drug administration in this case, the percentage
of the total number of osteons mineralizing was: femur 2 . 1 % ; tibia
0.65%; fibula 2.4%; metatarsal 1.06%.

(B)

The number of quiescent (fully formed) osteons per mineralizing osteon
were: femur 45.4; tibia 154; fibula 41.1; metatarsal 94.3.

(C)

From the vascular channels/mm' for each bone the banded osteons/mm',
thus osteons/mm' mineralizing in 40 days, may be calculated: femur
0.29; tibia 0.091; tibula 0.29; metatarsal 0.18. Reasoning elaborated
elsewhere reveals that these figures are representative of mineralizing
osteons/mm' also.

(D)

Since 40 days is 0.113 years the proportion of osteons undergoing
minerahzation in a year can be calculated: femur 18.7%; tibia 5.9%;
fibula 21.4%; metatarsal 9.4%.

(E)

The biological half-life of osteons may now be estimated. Note that
osteons comprise about 0.3 of the total cortices" and that a different
half-life for the entire cortex wifl be calculated from direct measurement.
Osteon half-lives are: femur 2.7; tibia 8.5; tibula 2.4; metatarsal 5.3,
all in years.

(F)

Several striking features emerge from the above measurements: the
long half-life of osteons, the similarity of the fibula and femur in
remodelling activity in this patient, the decrease in remodelling activity
as examination proceeds from proximal to distal (suggesting that in the
axial skeleton higher rates occur in this patient) and the remarkable inactivity of the tibia. One wonders if the tibial values reflect a general
characteristic or if unrecognized disease affected this bone, but not the
fibula, in this patient.
It is reasonably assumed that as much bone is broken down as is formed
in a given unit time, barring certain pathological states. I f this be true
then the calculations in (1) should also apply to the rates of bone
destruction.

2

Osteon formation time: Here we will determine how long, on the average,
it took for an osteon to form in this patient in the bones examined. Two
separate approaches to the problem are possible in the present case. One
is based on the frequency distribution of banded osteons, the other on a
simple proportional measurement of width of the bands and width of the
osteons.
(A)

About 11% of the total banded osteons were doubly banded, tirst
in the outer, then in the inner third of the osteon's width. See Figure 2.
The outer bands average 20 u, the inner bands 6 u thick. A mean time
interval between labefling epochs of 7 weeks wifl be assumed. This
is the time during which all of the doubly banded osteons formed.
If this were the mean time for all osteons there should be about as
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many that formed faster than 7 weeks as formed slower. The faster
ones would exhibit one band but the slower ones would exhibit two
bands, one of which was in the middle third of the osteon. Osteons
singly banded in either middle or outer thirds constitute about 40%
of the total but there were only 3 doubly banded osteons one of whose
bands was in the middle third, in 344 counted. This suggests that the
mean osteon formation time is less than 7 weeks. A period of about
5 weeks wfll be assumed because of the following reasoning.
(B)

The average osteon width was 80 u. The average width of the middle
and outer third achromycin bands in doubly banded osteons was 26 u.
These bands were labelled during a drug administration time of 11 days.
80/26 X 11 should be the time of osteon formation. This is 34 days.
It is not certain that ignoring the first 3 days of drug administration
is justified or that the rate of osteon formation is steady, however,
matters which we have assumed to be the case for the moment. Nevertheless the evidence is compatible with an osteon formation time of
about 5 weeks in this patient.

(C)

Assuming 5 weeks to be correct, 2.4 u of osteoid a day were elaborated
in mineralizing osteons in this patient.

3. Instantaneous percentage of osteoid ieamj;'."." This is the percent longitudinal
vascular channels containing mineralizing bone and thus a seam at any one
moment. It is assumed here that the percentage of osteoid seams and the
percentage of labelled osteons are equivalent. Subsequent publications will
document this assumption.
(A) Assume osteon formation rate and numbers were equal during the first
and initial part of the second drug administration periods. Then half
the singly banded osteons were labelled in the first 11 day period.
During 11 days some osteons completed, while others commenced,
formation, causing some overlap. The overlap should be about 11/35
of the instantaneous value. On this basis the value of osteons forming
at any one moment for the femur is 0.75''^. The value found at
amputation was 0.1%. This indicates that the vascular events preceding
gangrene markedly retarded new osteoid formation. The reader should
note that the somewhat unrealistic assumptions made here are unfavorable
to the qualitative result derived. The retardation in bone forming rate
which occurred during the second achromycin administration epoch
was probably greater by about 40% than the figure we quote.
(B)

4.

Using a conversion factor of 0.36", the incidence of banded osteons
can be converted to supply the instantaneous value of osteoid seams.
Chart I I I lists them.

Turnover of entire diaphysis: Because there are marked variations in the
proportions of Haversian to extra-Haversian bone in various bones and in

(a) 11 days drug dosageH-35 days osteon formation time.
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various ages, determination of osteon turnover or half-life does not tell us
about turnover or half-life of the entire bone cross-section. Tetracychne
labelling permits a direct measurement of entire cross-section turnover to be
made by planimetric means.
(A)

A representative femoral cross-section was measured with the Leitz
integrating eyepiece micrometer. 10% of the area was vascular channel
and 0.58% was banded by achromycin. The volume of osteocytes and
canaliculae is roughly 2%.
Thus whfle 0.58% of the total cortical volume was banded, 0.63% of
the dry, fat-free cortical mass was banded, assuming uniform bone
density, by 40 days of achromycin dosage.''
We calculate that 0.018% of this femur was mineralized through new
bone formation per day. According to previous reasoning this is also
the amount undergoing destruction per day. If the patient's vascular
difficulties retarded bone formation during the second achromycin
dosage period, this figure and those below are too small by a factor of,
at most, 40%.

(B)

I f the percent of mass undergoing mineralization per day is dependent
on the percentage of banded osteons, estimates of mineralizing mass
per day can be calculated for the other bones by simple proportion.
Values are: tibia 0.0058%; fibula 0.018%; metatarsal 0.011%.

(C)

Bone turnover as utilized here means the sum total of bone being
formed and degraded. This is twice the formation quantity. The values
per day: femur 0.036%; tibia 0.012%; fibula 0.036%; metatarsal
0.022%. These are precent of mass, or percent of osseous volume
excluding vascular and cellular volume. These measurements assume
a normal balance between bone formation and destruction, something
probably not present in the particular case we present. Another, direct
means of measuring bone resorption quantity and rate is needed to
evaluate bone turnover in disease states such as osteomalacia and
senile osteoporosis.

(D)

The remodelling rates and quantities of the various bones may now
be compared with each other. In terms of mass per unit volume turned
over, with the femur set arbitrarily at 100, the values are: femur 100;
tibia 19; fibula 101; metatarsal 61.
In terms of the absolute mass turning over in the middle thirds of
the bones, using the banded osteons per complete cross-section as a
means of proportional comparison, and with the femur set arbitrarily
at 100, the values are: femur 100; tibia 19; fibula 15; metatarsal 7.5.
In these calculations we assume there is no significant difference in the

(b) Bone density is not uniform at the macroscopic or microscopic levels but it is permissible at
present to assume a uniform average density. For some work on density variations consult
references 29, 31.
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size of osteons in the various bones. If high precision is required, this
assumption would require documentation by measurements on the
separate bones.
(E)

The mean half-life of the entire cortex may now be calculated, using
percent of mass mineralizing per day as the base. The values are,
in years: femur 7.6; tibia 24.2; fibula 7.6; metatarsal 12.6.

(F)

It wfll be noted that the osteon half-life is about 0.3 the above values.
This suggests that there are different turnover rates for Haversian and
extra-Haversian bone.
This inference is substantiated by tinding appreciable portions of circumferential lamellae in extra-Haversian bone even in very old patients.
Since circumferential lamellae form during appositional growth in all
phases of childhood, to be later partially replaced by osteons, it is
probable that the circumferential lamellae in this patient's extra-Haversian bone is older than the half-life values suggest, in some instances
probably 40 years old. It may be noted here that micropetrosis affects
extra-Haversian bone, particularly circumferential lamellae, long before
it occurs in Haversian bone. Micropetrosis is related to the biological
age of the bone affected and is not found in young bone." These points
also suggest a much longer half-life for extra-Haversian than for
Haversian bone.

5. Locus of remodelling activity: The distribution of banded osteons in the
cortical thirds is inhomogeneous. Most of the remodelling activity occurs
in the outer third of the cortex. In the femur, correction for the difference
in vascular channels/mm' between periosteal and endosteal surfaces balances
the difference out, but this correction does not balance out the preference
for outer third remodelling activity in the rest of the bones. These facts
pose two questions: why should remodelling activity concentrate near the
periosteal surfaces, and why are there more vascular channels there than
elsewhere? While a peculiarity of periosteal blood supply might be postulated,
it is also possible that the greater surface stresses and strains play a role.
This is a problem which should prove amenable to experiment using tetracycline
labelling as an investigative method.
6. The case we present offers an opportunity to check the thesis that one of
the factors causing bone cefls to die in vivo"" is age. We performed counts
of percent empty lacunae in this case which reveal:
Banded osteons (known to be younger than 95 days) had an average of 2.1%
empty lacunae.
The inner band of doubly banded osteons had 0.5%; the outer band 2.3%
empty lacunae. (Larger differences in empty lacunae between central and
peripheral lacunae usuafly occur in human Haversian systems so this is a
poor index of how many cells might die in 95 days).
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Mature, normally mineralized osteons exhibit an average of 18.5% empty
lacunae.
Extra-Haversian bone exhibits an average of 55.7% empty lacunae, but with
variations. Micropetrotic bone for example comprises about 10% of the
femur (on which these counts were done) but is 100% dead. It is noteworthy that no banded micropetrotic areas were seen in any of the 20 sections
scanned for this purpose or in any of the 42 other cases available to us which
are labelled in vivo with tetracyclines.
It appears that the empty-lacuna counting technique might serve as a means
of assigning relative ages to various parts of the same bone, extraneous factors
being absent. In this case a definite correlation between age of the bone
and percent empty lacunae exists.
DISCUSSION
A. ) We wish to emphasize that the foregoing measurements and calculations
are valid only for the diaphyses of the bones of the case examined. Extrapolations to the whole bone or skeleton or to man as a whole are not justified.
There is reason to expect that in the future factors of equivalence may be
determined which will permit such extrapolation.' Such factors would prove
invaluable in skeletal research and clinical work.
B. ) The behavior of tetracyclines is not necessarily representative of the behavior
of all bone-seeking substances. Differences in ionic size, sterism, charge,
solubility, dielectric constant, chemistry, hydration shells and other factors
make such similarity unlikely. Nevertheless it is possible in some instances
that equivalence factors are determinable which would permit the behavior
of tetracyclines and some other hypothetical substance to be equated. Some
likely candidates, with the qualifications below in mind, are lead, strontium,
radium and calcium.
As an example of how misleading the figures on the amount of bone
labelled per day by achromycin may be, consider the following: Partly
published work'.'" reveals that in mineralizing osteons containing an osteoid
seam there is a thick zone of permeability beyond the seam to diverse ions
and large molecules. The zone thickness usually exceeds 15 u and represents
the instantaneous volume of the mineralizing osteon which is readily permeable
to these substances. Achromycin, however, deposits only in a thin band at
the periphery of the seam," affecting a volume of bone smaller by a factor
of about 20. Such a difference in behavior reqiuies explanation and makes one
cautious about assuming permeability similarities in two different substances.
C. ) This paper deals with only one aspect of bone turnover as that term is
commonly understood, and that is bone formation and bone destruction.
These are not the only mechanisms by which bone-seeking substances may
enter or leave the skeleton, and therefore not the only important mechanisms
involved in radiobiological turnover and exchange work with bone. It is
now possible, however, to assign turnover, in the sense used by us, some
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quantitative meaning so that other modes of turnover may be placed in
perspective.
D. ) The techniques which we have utilized in this work, and the manner in which
we have applied these techniques, should pave the way for accurate measurement of normal osteoblastic activity in man. This is because the newly
mineralizing bone labelled by tetracyclines must be formed by osteoblasts,
and measuring the product is equivalent to measuring the production rate
directly.
E. ) With the above means it should be possible to determine what and how
various factors affect osteoblastic activity. For example, do estrogens really
accelerate osteoblastic activity in man, or do they exert a different effect?
How do the corticoids, thyroxin and growth hormone act and what is their
relative importance? These are some of the questions we hope to be able to
answer in the future. It is astonishing how little hard, factual knowledge
exists at present and serves as a basis for a large edifice of clinical theory
concerning osteoblastic activity.'.'
F. ) When the factors affecting osteoblastic activity in man have been recognized
through work on the lines suggested above, the clinician will be able to cure
osteoporosis of any type, to affect bone growth in any desired manner and to
cause fractures to heal more dependably and in less time than is currently
required. Much work, of course, lies between us and such capabilities.
G. ) The bone formation studied in the present case was lamellar bone formation.
It has been pointed out elsewhere that fibrous and lameflar bone osteoblastic
activity differ in some manner in their chemical processes and in their regulatory mechanisms.'" In past experimental work on osteoblastic activity,
failure to distinguish between these two fundamental bone types necessarily
invalidates the interpretation of such research.' '
SUMMARY
In vivo tetracycline labelling of bones from one patient, from which undecalcified
sections of the femur, tibia, fibula and metatarsal were made, permitted the direct
measurement or estimation in a 57 year old man of the following aspects of bone
physiology:
Osteon turnover rate and half-life in the various bones examined.
Total diaphyseal bone turnover rate and half-life in the various bones examined.
Mean time of osteon formation.
Locus of the major part of bone remodelling activity.
Comparison of turnover rates in different bones.
Quantitation of bone formation and destruction per unit time and volume in the
bones examined.
The techniques used in making the above determinations offer new means of
studying human bone physiology. Within their limitations of scope, they should prove
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useful in advancing our knowledge of skeletal dynamics.
The data presented in this paper are the first time such direct measurements have
been made in man.
APPENDEX ( A )
CASE PRESENTATION
Briefly, a 57 year old Caucasian male developed an aortic aneurysm which was
resected and replaced with a prosthesis. An interval of good health followed. Then
infection and leakage, after several temporizing surgical procedures, led to complete
ligation of the blood supply to the left lower extremity, gangrene and pertrochanteric
amputation. These events occurred during two separate hospitalizations in each of
which the patient received known amounts of achromycin for known time periods.
There were no objective or subjective circulatory difficulties in his lower extremities
until a thrombophlebitis of 5 days duration appeared on the 48th day after first achromycin administration. Transient circulatory difficulty appeared on the 75th day after
a surgical procedure. Gangrene occurred on the 97th day after ligation of all collaterals
to the limb and extirpation of the entire left limb of the arterial prosthesis. Amputation
was done on the 102nd day. The amputated hmb provided the material for the
present study.
Achromycin was administered in dosage of 2.0 gm/day on the following days,
numbering them from the day of first administration 1-3; 11-21; 63-88. No achromycin
was given on the other days. These periods will be referred to subsequently as the
first and second achromycin epochs, days 1-3 being ignored.
Multiple other antibiotics were administered but no other tetracyclines. ( A l l of
the other antibiotics and the tetracyclines have been tested in vitro for bone staining:
only the tetracyclines fluoresce and stain undecalcified bone visibly.)
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